Literature DB >> 26732615

Cost-effectiveness of adherence-enhancing interventions: a systematic review.

Tzahit Simon-Tuval1, Peter J Neumann2, Dan Greenberg1.   

Abstract

Low patient adherence to health-related interventions is a major barrier to achieving healthcare goals and is associated with very high avoidable costs. Although several studies suggest that adherence-enhancing interventions can improve health outcomes, economic evaluations of these interventions are scarce. Systematic reviews published to date are limited to interventions to enhance adherence to pharmaceuticals or to specific diseases and interventions. The authors' objective was to examine the evidence regarding the cost-effectiveness of adherence-enhancing interventions in healthcare and what conclusion could be drawn about these interventions. The present systematic review included 43 original studies and assessed the current evidence regarding the cost-effectiveness of a broad array of interventions aimed at enhancing adherence to medications, medical devices, screening tests and lifestyle behaviors. The authors found that although the majority of adherence-enhancing interventions were cost-effective or cost-saving, variation exists within different intervention types. Further research on the sustainability of adherence improvements is needed in order to accurately evaluate interventions' long-term benefits.

Entities:  

Keywords:  adherence; compliance; cost; cost-effectiveness analysis; quality adjusted life-year (QALY); systematic review

Mesh:

Year:  2016        PMID: 26732615     DOI: 10.1586/14737167.2016.1138858

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  8 in total

Review 1.  Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness.

Authors:  Clara Marquina; Ella Zomer; Sandra Vargas-Torres; Sophia Zoungas; Richard Ofori-Asenso; Danny Liew; Zanfina Ademi
Journal:  Pharmacoeconomics       Date:  2020-10       Impact factor: 4.981

2.  Cost and Cost-Effectiveness of Incentives for Viral Suppression in People Living with HIV.

Authors:  Laura J Dunlap; Stephen Orme; Gary A Zarkin; David R Holtgrave; Catherine Maulsby; Andrew M Rodewald; August F Holtyn; Kenneth Silverman
Journal:  AIDS Behav       Date:  2021-08-26

3.  Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study.

Authors:  Tamás Ágh; Maja Ortner Hadžiabdić; Kristina Garuoliene; Anne Gerd Granas; Emma Aarnio; Enrica Menditto; João Gregório; Pilar Barnestein-Fonseca; Vildan Mevsim; Przemysław Kardas
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

4.  Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study).

Authors:  Alba Sánchez-Viñas; Carmen Corral-Partearroyo; Montserrat Gil-Girbau; M Teresa Peñarrubia-María; Carmen Gallardo-González; María-Del-Carmen Olmos-Palenzuela; Ignacio Aznar-Lou; Antoni Serrano-Blanco; Maria Rubio-Valera
Journal:  BMC Prim Care       Date:  2022-07-05

5.  The impact of a pharmacist-led educational interview on medication adherence of Saudi patients with epilepsy.

Authors:  Refah AlAjmi; Sinaa Al-Aqeel; Salah Baz
Journal:  Patient Prefer Adherence       Date:  2017-05-18       Impact factor: 2.711

6.  Cost-effectiveness of an adherence-enhancing intervention for gout based on real-world data.

Authors:  Lydia Wenxin Lin; Gim Gee Teng; Anita Yee Nah Lim; Joanne Su-Yin Yoong; Niklas Zethraeus; Hwee-Lin Wee
Journal:  Int J Rheum Dis       Date:  2018-12-16       Impact factor: 2.454

7.  Cost-Utility Analysis of a Medication Adherence Management Service Alongside a Cluster Randomized Control Trial in Community Pharmacy.

Authors:  Maria-Isabel Valverde-Merino; Fernando Martinez-Martinez; Leticia Garcia-Mochon; Shalom I Benrimoj; Amaia Malet-Larrea; Beatriz Perez-Escamilla; Maria Jose Zarzuelo; Andrea Torres-Robles; Miguel Angel Gastelurrutia; Raquel Varas-Doval; Tamara Peiro Zorrilla; Victoria Garcia-Cardenas
Journal:  Patient Prefer Adherence       Date:  2021-10-24       Impact factor: 2.711

8.  Warfarin Adherence Among Patients with Atrial Fibrillation in Rural Area of Dongyang, China: A Questionnaire-Based Study.

Authors:  Huadong Chen; Xing'e Xu; Jiren Peng; Xuan Ge; Jing'an Zhang; Qianqian Dong; Xiunan Jiang; Piaopiao Li
Journal:  Patient Prefer Adherence       Date:  2022-08-25       Impact factor: 2.314

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.